Compounds > bucladesine

bucladesine and Carcinoma 256, Walker

bucladesine has been researched along with Carcinoma 256, Walker in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (71.43)	18.7374
1990's	4 (28.57)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Tisdale, MJ	2
Delikatny, SJ; Mokashi, S; Orr, FW	1
Benítez-Verguizas, J; Esbrit, P	1
de Miguel, F; Esbrit, P	1
Horita, T; Kasugai, S; Miyamoto, K; Ohya, K; Waki, Y	1
Costa Rosa, LF; Kazantzis, M; Seelaender, MC	1
Cho-Chung, YS; Clair, T; Parkison, C; Yi, PN	1
Cho-Chung, YS; Clair, T	1
Phillips, BJ; Tisdale, MJ	1
Cho-Chung, YS; Clair, T; Porper, R	1
Cho-Chung, YS; Clair, T; Huffman, P	1
Cho-Chung, YS; Newcomer, SF	1
Cho-Chung, YS	1

Other Studies

14 other study(ies) available for bucladesine and Carcinoma 256, Walker

Article	Year
Effect of methionine deprivation on S-adenosylmethionine decarboxylase of tumour cells. Biochimica et biophysica acta, 1981, Jul-17, Volume: 675, Issue:3-4 Topics: Adenosylmethionine Decarboxylase; Animals; Bucladesine; Carboxy-Lyases; Carcinoma 256, Walker; Cells, Cultured; Cyclic AMP; Cycloleucine; Enzyme Induction; Homocysteine; Kinetics; Lymphoma; Methionine; Polyamines	1981
Potentiation of the growth inhibitory effects of adenosine 3',5'-monophosphate analogues by homocysteine. Biochemical pharmacology, 1982, Mar-15, Volume: 31, Issue:6 Topics: Animals; Bucladesine; Carcinoma 256, Walker; Drug Synergism; Homocysteine; Methylation; S-Adenosylhomocysteine	1982
Relationships between chemotaxis, chemotactic modulators, and cyclic nucleotide levels in tumor cells. Cancer research, 1983, Volume: 43, Issue:5 Topics: Animals; Bucladesine; Carcinoma 256, Walker; Cell Line; Chemotactic Factors; Chemotaxis; Chemotaxis, Leukocyte; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Dinoprost; Dinoprostone; Female; Prostaglandins A; Prostaglandins E; Prostaglandins F; Rats	1983
Proliferative effect of parathyroid hormone-related protein on the hypercalcemic Walker 256 carcinoma cell line. Biochemical and biophysical research communications, 1994, Feb-15, Volume: 198, Issue:3 Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Antibodies; Bucladesine; Calcium; Carcinoma 256, Walker; Cattle; Cell Division; Cytosol; Dantrolene; Dichlororibofuranosylbenzimidazole; DNA, Neoplasm; Female; Flow Cytometry; Humans; Hypercalcemia; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Peptide Fragments; Proteins; Rats; Rats, Wistar; Teriparatide; Thionucleotides; Thymidine; Tumor Cells, Cultured	1994
Characterization of calcium transport in the luminal and the basolateral membrane from kidney cortex of hypercalcemic rats bearing the Walker 256 carcinosarcoma. Bone and mineral, 1993, Volume: 23, Issue:1 Topics: Adenosine Triphosphate; Animals; Biological Transport; Bucladesine; Calcium; Carcinoma 256, Walker; Cell Membrane; Female; Hypercalcemia; Kidney Cortex; Microscopy, Electron; Microvilli; Parathyroid Hormone-Related Protein; Proteins; Rats; Rats, Wistar; Vanadates	1993
Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4. Biochemical pharmacology, 1997, Sep-01, Volume: 54, Issue:5 Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Bone Marrow Cells; Bone Resorption; Bucladesine; Calcification, Physiologic; Carcinoma 256, Walker; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 4; Female; Mice; Milrinone; Osteoclasts; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyridones; Rats; Rats, Wistar; Xanthines	1997
The effect of adrenaline and Walker-256 tumour-induced cachexia upon Kupffer cell metabolism. Cell biochemistry and function, 1999, Volume: 17, Issue:3 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Bucladesine; Cachexia; Calcium; Carcinoma 256, Walker; Cells, Cultured; Cyclic AMP; Dinoprostone; Epinephrine; Isoproterenol; Kupffer Cells; Male; Phenylephrine; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1	1999
Comparative studies on cyclic AMP binding and protein kinase in cyclic AMP-responsive and -unresponsive Walker 256 mammary carcinomas. The Journal of biological chemistry, 1977, Sep-25, Volume: 252, Issue:18 Topics: Adenosine; Animals; Bucladesine; Carcinoma 256, Walker; Cyclic AMP; Drug Resistance; Hydrogen-Ion Concentration; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Protamine Kinase; Protein Kinases; Rats; Receptors, Cyclic AMP; Temperature	1977
The role of cAMP on neoplastic cell growth and regression. III. Altered cAMP-binding in DBcAMP-unresponsive Walker 256 mammary carcinoma. Biochemical and biophysical research communications, 1975, May-19, Volume: 64, Issue:2 Topics: Animals; Bucladesine; Carcinoma 256, Walker; Cyclic AMP; Cycloheximide; Cytosol; Dactinomycin; Protein Binding; Rats; Time Factors	1975
The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells. Biochemical pharmacology, 1976, Nov-01, Volume: 25, Issue:21 Topics: Alkylating Agents; Animals; Aziridines; Bucladesine; Carcinoma 256, Walker; Cell Line; Cells, Cultured; Chlorambucil; Cyclic AMP; Lymphoma; Protein Kinases; Stimulation, Chemical; Time Factors	1976
Cyclic AMP-binding proteins and protein kinase during regression of Walker 256 mammary carcinoma. The Journal of biological chemistry, 1977, Sep-25, Volume: 252, Issue:18 Topics: Animals; Bucladesine; Carcinoma 256, Walker; Cell Nucleus; Centrifugation, Density Gradient; Cytoplasm; Drug Resistance; Mammary Neoplasms, Experimental; Protamine Kinase; Protein Kinase Inhibitors; Protein Kinases; Rats; Receptors, Cyclic AMP; Structure-Activity Relationship	1977
Loss of nuclear cyclic AMP binding in cyclic AMP-unresponsive Walker 256 mammary carcinoma. The Journal of biological chemistry, 1977, Sep-25, Volume: 252, Issue:18 Topics: Animals; Bucladesine; Carcinoma 256, Walker; Cell Nucleus; Cytoplasm; Drug Resistance; Mammary Neoplasms, Experimental; Prostaglandins E; Protein Kinases; Rats; Receptors, Cyclic AMP	1977
Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma. Cancer research, 1977, Volume: 37, Issue:12 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Adenylyl Imidodiphosphate; Animals; Bucladesine; Carcinoma 256, Walker; Cyclic AMP; Female; Guanosine Triphosphate; In Vitro Techniques; Kinetics; Magnesium; Mammary Neoplasms, Experimental; Prostaglandins E; Rats; Remission, Spontaneous; Sodium Fluoride	1977
In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives. Cancer research, 1974, Volume: 34, Issue:12 Topics: Animals; Benz(a)Anthracenes; Bucladesine; Carcinogens; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Cyclic AMP; DNA, Neoplasm; Dose-Response Relationship, Drug; Estrogens; Female; Fibrosarcoma; Liver Neoplasms; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Rats; Rats, Inbred Strains; Ribonucleases; Sarcoma, Experimental; Transplantation, Homologous	1974